FindMyKOL
Clinical trialNCT01383382CompletedObservational

Transforming PCI Informed Consent Into an Evidence-based Decision-making Tool

NCT01383382 is an observational study sponsored by Saint Luke's Health System. As of 21 Nov 2026, it is completed. It studies Non-emergent Percutaneous Coronary Intervention (PCI). The registry lists an enrollment of 1,399 participants at 7 sites in 1 country. The registry lists a start date of 30 Sept 2009 and a primary completion date of 31 Oct 2011. One of its registered investigators has a FindMyKOL profile.

SponsorSaint Luke's Health System →Enrollment1,399Non-emergent Percutaneous Coronary Intervention (PCI)
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01383382
FieldValue
Registry IDNCT01383382
StatusCompleted
Study typeObservational study
Lead sponsorSaint Luke's Health System
Enrollment1,399
Registered sites7
Countries1
ConditionsNon-emergent Percutaneous Coronary Intervention (PCI)
Start30 Sept 2009
Primary completion31 Oct 2011
Study completion30 Sept 2012
Last update posted10 Sept 2012

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Using individualized patient estimates of procedural risks and benefits, this project will transform the process of informed consent for coronary angioplasty into a dynamic educational tool for patients and physicians and is a direct response to the Institute of Medicine's call for a more evidence-based, efficient, patient-centered healthcare system. It is hypothesized that patients will develop a greater understanding of their individual risks and benefits from PCI, will be empowered to more actively engage in shared decision-making, as well as have improved awareness of their responsibility to adhere to dual anti-platelet therapy if treated with a drug eluting stent (risks for target vessel revascularization with bare metal and drug eluting stents are also provided in the new consent form). It is also anticipated that physicians, in turn, will use these individualized estimates to better discriminate between risks and benefits among different bleeding avoidance therapies so as to improve the safety and cost-effectiveness of PCI.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site
  • Kaiser Permanente

    Oakland

Illinois, United States1 site
  • Prairie Education and Research Cooperative

    Springfield

Massachusetts, United States1 site
  • Baystate Medical Center

    Springfield

Michigan, United States1 site
  • Henry Ford Health System

    Detroit

Missouri, United States2 sites
  • Saint Luke's Hospital of Kansas City

    Kansas City

  • Barnes-Jewish Hospital/washington University School of Medicine

    St Louis

Texas, United States1 site
  • Baylor Research Institute

    Plano

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichigan: 1 siteMI1New YorkNYMassachusetts: 1 siteMA1Rhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinois: 1 siteIL1IndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 siteCA1NevadaNVWyomingWYNebraskaNEMissouri: 2 sitesMO2KentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexas: 1 siteTX1FloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01383382

Each answer restates registry values shown on this page.

What is NCT01383382?

NCT01383382 is an observational study sponsored by Saint Luke's Health System. It studies Non-emergent Percutaneous Coronary Intervention (PCI).

Who leads NCT01383382?

The registry names John A Spertus, MD, MPH (principal investigator, St. Luke's Hospital, Kansas City, Missouri) as the overall official.

Where does NCT01383382 run?

The registry lists 7 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT01383382 end?

The registry lists a primary completion date of 31 Oct 2011 and a study completion date of 30 Sept 2012. The sponsor last updated the record on 10 Sept 2012.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.